Back
Structure Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
30
GPCR
Structure Therapeutics
Last Price:
$21.76
Seasonality Move:
1.13%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.53 | Sell |
| 20-day SMA: | 24.71 | Sell |
| 50-day SMA: | 21.86 | Sell |
| 200-day SMA: | 30.04 | Sell |
| 8-day EMA: | 23.22 | Sell |
| 20-day EMA: | 23.75 | Sell |
| 50-day EMA: | 23.34 | Sell |
| 200-day EMA: | 28.33 | Sell |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.05 | Sell |
| Relative Strength Index (14 RSI): | 39.75 | Sell |
| Chaikin Money Flow: | -391134 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (23.31 - 26.43) | Sell |
| Bollinger Bands (100): | (19.59 - 27.33) | Sell |
Structure Therapeutics Technical Analysis
| May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 21.76 while GPCR 8-day simple moving average is 23.53, which is a Sell signal.
-
The stock price of GPCR is 21.76 while Structure Therapeutics 20-day SMA is 24.71, which makes it a Sell.
-
Structure Therapeutics 50-day simple moving average is 21.86 while GPCR share price is 21.76, making it a Sell technically.
-
GPCR stock price is 21.76 and Structure Therapeutics 200-day simple moving average is 30.04, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
30
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a SellThe current Structure Therapeutics [GPCR] share price is $21.76. The Score for GPCR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
1.3B
Price in USD:
21.76
Share Volume:
731.3K
Structure Therapeutics 52-Week Range
52-Week High:
62.74
52-Week Low:
13.22
Sell
30
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?The Structure Therapeutics stock price is 21.76 USD today.
-
Will GPCR stock go up or go down?Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Structure Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
-
Structure Therapeutics share price is 21.76 while GPCR 8-day exponential moving average is 23.22, which is a Sell signal.
-
The stock price of GPCR is 21.76 while Structure Therapeutics 20-day EMA is 23.75, which makes it a Sell.
-
Structure Therapeutics 50-day exponential moving average is 23.34 while GPCR share price is 21.76, making it a Sell technically.
-
GPCR stock price is 21.76 and Structure Therapeutics 200-day simple moving average is 28.33, creating a Sell signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.34 per share, and a decrease next year of $0.78 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
-
GPCR Moving Average Covergence Divergence (MACD) indicator is -0.05, suggesting Structure Therapeutics is a Sell
-
Structure Therapeutics Relative Strength Index (RSI) is 39.75, which suggest Structure Therapeutics is oversold
-
The Bollinger Bands (25) for Structure Therapeutics is (23.31 - 26.43), which suggest Structure Therapeutics is a Sell
-
The Bollinger Bands (100) for Structure Therapeutics is (19.59 - 27.33), which suggest Structure Therapeutics is a Sell
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.